A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer

INTRODUCTION: The aim of this study was to compare TOMOX versus FOLFOX4 as first-line treatment of advanced colorectal cancer (CRC). MATERIALS AND METHODS: 191 chemotherapy-naïve patients were randomized to receive TOMOX or FOLFOX4. Patients were evaluated every 3 months and chemotherapy was continu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gravalos, Cristina, Salut, Antonieta, García-Girón, Carlos, García-Carbonero, Rocío, León, Ana Isabel, Sevilla, Isabel, Maurel, Joan, Esteban, Beatriz, García-Rico, Eduardo, Murias, Adolfo, Cortés-Funes, Hernán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427491/
https://www.ncbi.nlm.nih.gov/pubmed/22855138
http://dx.doi.org/10.1007/s12094-012-0843-x

Ejemplares similares

Ejemplares similares